Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting?

Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting?

Item
http://www.wikidata.org/entity/Q28391808
β2-Adrenergic agonists attenuate organic dust-induced lung inflammationFormoterol is more effective than salmeterol in suppressing neutrophil reactivityInflammation: The Common Pathway of Stress-Related Diseases.Salmeterol Efficacy and Bias in the Activation and Kinase-Mediated Desensitization of β2-Adrenergic Receptors.Anti-Inflammatory Effects of β2-Receptor Agonists Salbutamol and Terbutaline Are Mediated by MKP-1.β-Blockers have differential effects on the murine asthma phenotype.The beta-2-adrenoreceptor agonists, formoterol and indacaterol, but not salbutamol, effectively suppress the reactivity of human neutrophils in vitro.Bronchodilators, receptors and cross-talk: Together is better?Cyclic Adenosine Monophosphate-Mediated Enhancement of Vascular Endothelial Growth Factor Released by Differentiated Human Monocytic Cells: The Role of Protein Kinase A.The β2-adrenoceptor agonist clenbuterol reduces the neuroinflammatory response, neutrophil infiltration and apoptosis following intra-striatal IL-1β administration to rats.Combination Therapy with Budesonide and Salmeterol in Experimental Allergic Inflammation.Tulobuterol patch alleviates allergic asthmic inflammation by blockade of Syk and NF-κB activation in mice.
P2860

Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting?

Item
http://www.wikidata.org/entity/Q28391808
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting?
@ast
Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting?
@en
Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting?
@nl
type
label
Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting?
@ast
Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting?
@en
Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting?
@nl
prefLabel
Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting?
@ast
Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting?
@en
Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting?
@nl
P1433
P1476
P2093
P275
P2860
P304
P31
P356
P407
P478
P577
P698
P921
P932
P356
P1433
P1476
Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting?
@en
P2093
P275
P2860
P304
P31
P356
P407
P478
P577
P698
P921
P932